Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

Michael Walter

Michael Walter
Managing Editor


Michael has more than 19 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

LATEST ARTICLES BY THIS AUTHOR

Semaglutide works fast, protecting the heart before weight loss kicks in
PCI just as successful when patients have a history of TAVR—but there are some added risks
Cardiology groups among the many voices asking Congress not to cut Medicaid
FDA approves popular ultrasound enhancing agent for pediatric patients
FDA gives AI-powered blood test for obstructive CAD breakthrough device designation
GE HealthCare debuts new wide-bore MRI scanner built with cardiology, oncology in mind
When valves fail: Surgeons share advice for treating high-risk patients with TAVR explant and SAVR
Gastric bypass surgery linked to lower heart attack risk than gastric sleeve
Obicetrapib linked to substantial reductions in LDL cholesterol for high-risk heart patients
TAVR and SAVR deliver similar outcomes for patients with low-flow, low-gradient aortic stenosis

Pagination

    • First page « First
    • Previous page ‹ Previous
    • Page …66
    • Page 67
    • Page 68
    • Page 69
    • Current page 70
    • Page 71
    • Page 72
    • Page 73
    • Page 74 …
    • Next page Next ›
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme